The association between estimated average glucose levels and fasting plasma glucose levels

OBJECTIVE: The level of hemoglobin A1c (HbA1c), also known as glycated hemoglobin, determines how well a patient's blood glucose level has been controlled over the previous 8-12 weeks. HbA1c levels help patients and doctors understand whether a particular diabetes treatment is working and whether adjustments need to be made to the treatment. Because the HbA1c level is a marker of blood glucose for the previous 120 days, average blood glucose levels can be estimated using HbA1c levels. Our aim in the present study was to investigate the relationship between estimated average glucose levels, as calculated by HbA1c levels, and fasting plasma glucose levels. METHODS: The fasting plasma glucose levels of 3891 diabetic patient samples (1497 male, 2394 female) were obtained from the laboratory information system used for HbA1c testing by the Department of Internal Medicine at the Izmir Bozyaka Training and Research Hospital in Turkey. These samples were selected from patient samples that had hemoglobin levels between 12 and 16 g/dL. The estimated glucose levels were calculated using the following formula: 28.7 x HbA1c - 46.7. Glucose and HbA1c levels were determined using hexokinase and high performance liquid chromatography (HPLC) methods, respectively. RESULTS: A strong positive correlation between fasting plasma glucose levels and estimated average blood glucose levels (r=0.757, p<0.05) was observed. The difference was statistically significant. CONCLUSION: Reporting the estimated average glucose level together with the HbA1c level is believed to assist patients and doctors determine the effectiveness of blood glucose control measures

Mechanical characterization of hybrid biocomposites reinforced with nonwoven hemp and unidirectional flax fibers

Fiber-reinforced polymers are widely used in many applications where high specific strength and high specific stiffness are required. Biocomposites have replaced synthetic-based fiber-reinforced polymers as a preferred option due to their environmental friendliness, ease of supply, and affordability. Comparable strength synthetic-fiber-reinforced polymers and biocomposites both have lower specific weights. This study aims to characterize hybrid biocomposites produced from unidirectional prepregs made of flax/polypropylene fibers and nonwoven mats made of hemp/polypropylene fibers. Research has also been conducted on how the number of layers and the stacking sequence affect the mechanical performance of hybrid biocomposites. Three different designs of biocomposite plates have been produced using compression molding. They were then subjected to tensile, compressive, shear, bending, Charpy impact, and drop-weight impact tests. According to the test results, it is found that each design has its own characteristics, and the characterized static and dynamic behaviors are very different from each other. Therefore, each biocomposite mentioned here may be a good candidate for engineering design based on the given engineering design criteria

The Effects of Acute and Chronic Hyperglycemia on Serum Paraoxonase Activity

Objectives: Paraoxonase (PON1) is a high density lipoprotein bound serum esterase that is synthesized by the liver which has ability to metabolize lipid peroxides hence playing an important role in protection against atherosclerosis. Our aim was to evaluate the effect of acute and chronic hyperglycemia on PON1 activity in order to clarify the effect of glucose homeostasis. Besides, the relation of hemoglobin A(1c) with triglyceride, total cholesterol, low density lipoprotein-cholesterol, high density lipoprotein-cholesterol and PON1/high density lipoprotein-cholesterol ratios which play role in the development of atherosclerosis was also evaluated

Hb SARREBOURG [beta 131(H9) Gln -> Arg, CAG > CGG] IN TURKEY

20th National Biochemistry Congress -- OCT 29-NOV 01, 2008 -- Nevsehir, TURKEYWOS: 000284221000008PubMed ID: 21077765We describe Hb Sarrebourg [beta 131(H9) Gln -> Arg, CAG > CGG] in four heterozygous members of a Turkish family. It was associated with iron deficiency in the proband

Validation of German Aortic Valve Score in a Multi-Surgeon Single Center

WOS: 000408048400005PubMed: 28492787Objective: Risk assessment for operative mortality is mandatory for all cardiac operations. For some operation types such as aortic valve repair, EuroSCORE II overestimates the mortality rate and a new scoring system (German AV score) has been developed for a more accurate assessment of operative risk. In this study, we aimed to validate German Aortic Valve Score in our clinic in patients undergoing isolated aortic valve replacement. Methods: A total of 35 patients who underwent isolated open aortic valve replacement between 2010 and 2013 were included. Patients with concomitant procedures and transcatheter aortic valve implantation were excluded. Patients' data were collected and analyzed retrospectively. Patients' risk scores EuroSCORE II were calculated online according to criteria described by EuroSCORE taskforce, Aortic Valve Scores were also calculated. Results: The mean age of patients was 61.14 +/- 13.25 years (range 29-80 years). The number of female patients was 14 (40%) and body mass index of 25 (71.43%) patients was in range of 22-35. Mean German Aortic Valve Score was 1.05 +/- 0.96 (min: 0 max: 4.98) and mean EuroSCORE was 2.30 +/- 2.60 (min: 0.62, max: 2.30). The Aortic Valve Score scale showed better discriminative capacity (AUC 0.647, 95% CI 0.439-0.854). The goodness of fit was x(2)HL[Aortic Valve Score]= 16.63; P= 0.436). EuroSCORE II scale had shown less discriminative capacity (AUC 0.397, 95% CI 0.200-0.597). The goodness of fit was good for both scales. The goodness of fit was x(2)HL[EuroSCORE II]= 30.10; P= 0.610. Conclusion: In conclusion, German AV score applies to our population with high predictive accuracy and goodness of fit